Literature DB >> 16029770

Using hormone treatment to reduce the adult height of tall girls: are women satisfied with the decision in later years?

Priscilla Pyett1, Jo Rayner, Alison Venn, Fiona Bruinsma, George Werther, Judith Lumley.   

Abstract

Treatment with synthetic oestrogens to reduce adult height has been available for tall girls since the 1950s. Treatment aims to reduce psychosocial problems associated with tall stature that might occur in adolescence or adulthood, but little is known about the long-term outcomes. This retrospective cohort study identified 1248 eligible women from the medical records of Australian paediatricians who assessed or treated tall girls between 1959 and 1993, and 184 women from self-referrals. They included girls who received oestrogen treatment (diethylstilbestrol or ethinyl estradiol) in adolescence (treated group) and those who had been assessed but did not receive treatment (untreated group). A total of 1243 (86.8%) women were traced and invited to participate in the study, and 67.9% of these women (396 treated and 448 untreated) agreed. This paper reports on women's satisfaction with the decision that was made to have treatment to reduce their adult height. In a postal questionnaire women were asked to comment on a range of issues including how they felt about their current height, the assessment and treatment procedures, and the decision whether or not to have treatment. While untreated women were almost unanimously glad they were not treated (99.1%), no matter how tall they became, 42.1% of the treated women expressed dissatisfaction with the decision that was made. There was no clear association between satisfaction with treatment and the women's final height. However, dissatisfaction was related to: (a) whether or not the girls had an active say in the decision-making; (b) to negative experiences of the assessment or treatment procedures; (c) to side effects experienced during the treatment period; and (d) to later side effects women believed were associated with the treatment. The study finds that qualitative analysis of comments made by treated women helps to explain their dissatisfaction with the decision to have treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16029770     DOI: 10.1016/j.socscimed.2005.03.016

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  Preliminary results of two novel devices for epiphysiodesis in the reduction of excessive predicted final height in tall stature.

Authors:  Andrea Laufer; Gregor Toporowski; Georg Gosheger; Ava von der Heiden; Jan Duedal Rölfing; Adrien Frommer; Anna Rachbauer; Carina Antfang; Robert Rödl; Bjoern Vogt
Journal:  J Orthop Traumatol       Date:  2022-09-17

2.  Looking back in time: conducting a cohort study of the long-term effects of treatment of adolescent tall girls with synthetic hormones.

Authors:  Fiona J Bruinsma; Jo-Anne Rayner; Alison J Venn; Priscilla Pyett; George Werther
Journal:  BMC Public Health       Date:  2011-11-25       Impact factor: 3.295

3.  Child height, health and human capital: Evidence using genetic markers.

Authors:  Stephanie von Hinke Kessler Scholder; George Davey Smith; Debbie A Lawlor; Carol Propper; Frank Windmeijer
Journal:  Eur Econ Rev       Date:  2013-01

4.  Etiology and Clinical Profile of Patients with Tall Stature: A Single-Center Experience.

Authors:  Alpesh Goyal; Viveka P Jyotsna; Arun K C Singh; Yashdeep Gupta; Rajesh Khadgawat
Journal:  Indian J Endocrinol Metab       Date:  2020-11-09

5.  Epiphysiodesis for the treatment of tall stature and leg length discrepancy.

Authors:  Madeleine Willegger; Markus Schreiner; Alexander Kolb; Reinhard Windhager; Catharina Chiari
Journal:  Wien Med Wochenschr       Date:  2021-03-18

6.  Medicalising short children with growth hormone? Ethical considerations of the underlying sociocultural aspects.

Authors:  Maria Cristina Murano
Journal:  Med Health Care Philos       Date:  2018-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.